Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313)
| Autor: | Sharma, P. *, Barlow, W.E., Godwin, A.K., Pathak, H., Isakova, K., Williams, D., Timms, K.M., Hartman, A.R., Wenstrup, R.J., Linden, H.M., Tripathy, D., Hortobagyi, G.N., Hayes, D.F. |
|---|---|
| Zdroj: | In Annals of Oncology March 2018 29(3):654-660 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|